Company Search:
Advanced Search
Sponsored Links
Imugene Limited Company Snapshot
Imugene Limited operates in the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Imugene Limited with three other companies in this sector in Australia: Medibio Ltd (2016 sales of 1.81 million Australian Dollars [US$1.43 million] ), Phosphagenics Limited (1.59 million Australian Dollars [US$1.26 million] of which 81% was Production and Personal Care), and Paradigm Biopharmaceuticals Ltd (1.39 million Australian Dollars [US$1.10 million] ).

Sales Analysis. Imugene Limited reported sales of A$1.56 million (US$1.24 million) for the fiscal year ending June of 2016. This represents an increase of 144.9% versus 2015, when the company's sales were A$638,676.00 . This was the third consecutive year of growth at Imugene Limited.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Imugene Limited
  Stock Performance Chart for Imugene Limited
  Stock Data: Recent Stock Performance:
  Current Price (7/21/2017): .02
(Figures in Australian Dollars)
1 Week 14.3%   13 Weeks 14.3%  
4 Weeks 0.0%   52 Weeks 88.2%  
Imugene Limited Key Data:
  Ticker: IMU Country: Australia
  Exchanges: Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2016 Sales 1,564,271
(Year Ending Jan 2017).
  Currency: Australian Dollars Market Cap: 34,642,872
  Fiscal Yr Ends: June Shares Outstanding: 2,165,179,518
  Share Type: Ordinary Closely Held Shares: 563,438,799
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.